AI Article Synopsis
Article Abstract
A porcine model has been established to study keratinocyte autografts as a model of human keratinocyte grafting. Keratinocyte autografts were placed on 104 full thickness wounds in 13 pigs and backed with 3 dressings which varied in their ability to maintain an occlusive environment. Sixteen control wounds were ungrafted. No take was found using a backing of woven viscose and cotton gauze. Take was 20% at day 16 using a backing of woven viscose and paraffin gauze. Serial biopsies showed that keratinocytes frequently attached to the interstices of the viscose dressing and difficulty in detaching the viscose caused loss of epidermis. Hydrogel sheet backing made assessment at day 10 difficult because of wound hydration but dressing removal, enabling exudate evaporation, produced 22% take at day 13. The development of improved dressing techniques is certainly necessary for improved graft take.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0007-1226(93)90173-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Experimental method for creating skin with acquired appendage dysfunction.
J Dermatol
December 2024
Department of Plastic and Reconstructive Surgery, The University of Tokyo Hospital, Tokyo, Japan.
Mammalian skin appendages, such as hair follicles and sweat glands, are essential for both esthetic and functional purposes. Conditions such as burns and ulcers can lead to dysfunction or loss of skin appendages and result in hair loss and dry skin, posing challenges in their regeneration. Existing animal models are insufficient for studying acquired dysfunction of skin appendages without underlying genetic causes.
View Article and Find Full Text PDFFast Autograft Generation Using Transferable 3D Keratinocyte Cell Sheet on PEDOT:PSS Composite PDMS Membrane for Enhancing Wound Healing.
Small
November 2024
Department of Nano-Bio Mechanical System Engineering, Jeonbuk National University, Jeonju-si, Jeollabuk-do, 54896, Republic of Korea.
The application of cell sheet technology for wound healing preserves dense cell tissue and the natural extracellular matrix (ECM), contributing to disease prevention. Despite the effectiveness of autologous and allograft cell sheets for wound healing, conventional cell sheets, although stable, may experience necrosis in their middle layers due to a lack of nutrients or oxygen. To address these issues, a novel approach is proposed to create cell sheets using mechanical and electrical stimulation.
View Article and Find Full Text PDFA Systematic Review of Case Series and Clinical Trials Investigating Regenerative Medicine for the Treatment of Vitiligo.
J Cosmet Dermatol
November 2024
Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Aims And Objectives: The aim of this study is to examine the efficacy and safety of various regenerative medicine treatments, such as cell therapy, platelet-rich plasma (PRP), plasma-poor platelet (PPP), plasma-rich fibrin (PRF), mesenchymal stem cells, stromal vascular fraction (SVF), exosomes, adipose-derived stem cells (ADSC), and stem cell-conditioned media (SC-CM), for treating vitiligo.
Method: We conducted a thorough search of major databases such as PubMed, Scopus, and Web of Science, and selected 48 articles based on specific criteria. We used EndNote X8 and Google Sheets to review and extract data from the articles.
Sustained Repigmentation in Vitiligo and Leukodermas Using Melanocyte-Keratinocyte Transplantation: 7 Years of Data.
Clin Cosmet Investig Dermatol
November 2024
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Background: The autologous non-cultured melanocyte-keratinocyte transplantation procedure (MKTP) has emerged as an effective treatment for various types of vitiligo and leukodermas. However, there is limited data on the long-term outcomes of the MKTP, especially in Thai patients.
Objective: To assess the long-term efficacy and safety of the MKTP in patients with vitiligo and other leukodermas.
Current Status of Biomedical Products for Gene and Cell Therapy of Recessive Dystrophic Epidermolysis Bullosa.
Int J Mol Sci
September 2024
Scientific Research Institute of Carcinogenesis, N. N. Blokhin National Medical Research Center of Oncology, Moscow 115522, Russia.
Article Synopsis
- - This review highlights current strategies and products in gene and cell therapy for treating recessive dystrophic epidermolysis bullosa (RDEB), a disorder linked to collagen type VII alpha 1 (C7) deficiency due to genetic defects.
- - Allogenic mesenchymal stem/stromal cells show the most potential, along with genetically modified autologous dermal fibroblast injections, as key approaches in RDEB cell therapy.
- - Gene therapy methods, including gene replacement with viral vectors and gene editing, have seen significant advancements, with successful developments such as ex vivo epidermal transplants and two-layer transplants enhancing treatment options for RDEB.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!